190 related articles for article (PubMed ID: 31176377)
1. Quantitative grip force assessment of muscular weakness in chronic inflammatory demyelinating polyneuropathy.
Klehmet J; Beutner S; Hoffmann S; Dornauer M; Paul F; Reilmann R; Brandt AU; Meisel A
BMC Neurol; 2019 Jun; 19(1):118. PubMed ID: 31176377
[TBL] [Abstract][Full Text] [Related]
2. Quantitative motor assessment of muscular weakness in myasthenia gravis: a pilot study.
Hoffmann S; Siedler J; Brandt AU; Piper SK; Kohler S; Sass C; Paul F; Reilmann R; Meisel A
BMC Neurol; 2015 Dec; 15():265. PubMed ID: 26701600
[TBL] [Abstract][Full Text] [Related]
3. Muscle performance relates to physical function and quality of life in long-term chronic inflammatory demyelinating polyradiculoneuropathy.
Harbo T; Andersen H; Overgaard K; Jakobsen J
J Peripher Nerv Syst; 2008 Sep; 13(3):208-17. PubMed ID: 18844787
[TBL] [Abstract][Full Text] [Related]
4. Vigorimeter grip strength in CIDP: a responsive tool that rapidly measures the effect of IVIG--the ICE study.
Vanhoutte EK; Latov N; Deng C; Hanna K; Hughes RA; Bril V; Dalakas MC; Donofrio P; van Doorn PA; Hartung HP; Merkies IS
Eur J Neurol; 2013 May; 20(5):748-55. PubMed ID: 22891893
[TBL] [Abstract][Full Text] [Related]
5. Confirming the efficacy of intravenous immunoglobulin in CIDP through minimum clinically important differences: shifting from statistical significance to clinical relevance.
Merkies IS; van Nes SI; Hanna K; Hughes RA; Deng C
J Neurol Neurosurg Psychiatry; 2010 Nov; 81(11):1194-9. PubMed ID: 20647554
[TBL] [Abstract][Full Text] [Related]
6. Chronic acquired demyelinating symmetric polyneuropathy classified by pattern of weakness.
Mygland A; Monstad P
Arch Neurol; 2003 Feb; 60(2):260-4. PubMed ID: 12580713
[TBL] [Abstract][Full Text] [Related]
7. Jamar hand-held grip dynamometry in chronic inflammatory demyelinating polyneuropathy.
Rajabally YA; Narasimhan M
J Neurol Sci; 2013 Feb; 325(1-2):36-8. PubMed ID: 23237145
[TBL] [Abstract][Full Text] [Related]
8. Muscle atrophy in chronic inflammatory demyelinating polyneuropathy: a computed tomography assessment.
Ohyama K; Koike H; Katsuno M; Takahashi M; Hashimoto R; Kawagashira Y; Iijima M; Adachi H; Watanabe H; Sobue G
Eur J Neurol; 2014 Jul; 21(7):1002-10. PubMed ID: 24684299
[TBL] [Abstract][Full Text] [Related]
9. Correlation of the patient's reported outcome Inflammatory-RODS with an objective metric in immune-mediated neuropathies.
Draak TH; Gorson KC; Vanhoutte EK; van Nes SI; van Doorn PA; Cornblath DR; van den Berg LH; Faber CG; Merkies IS;
Eur J Neurol; 2016 Jul; 23(7):1248-53. PubMed ID: 27129110
[TBL] [Abstract][Full Text] [Related]
10. Impairment and disability in 20 CIDP patients according to disease activity status.
Panaite PA; Renaud S; Kraftsik R; Steck AJ; Kuntzer T
J Peripher Nerv Syst; 2013 Sep; 18(3):241-6. PubMed ID: 24028192
[TBL] [Abstract][Full Text] [Related]
11. Timing and course of clinical response to intravenous immunoglobulin in chronic inflammatory demyelinating polyradiculoneuropathy.
Latov N; Deng C; Dalakas MC; Bril V; Donofrio P; Hanna K; Hartung HP; Hughes RA; Merkies IS; van Doorn PA;
Arch Neurol; 2010 Jul; 67(7):802-7. PubMed ID: 20457948
[TBL] [Abstract][Full Text] [Related]
12. A subset of fibromyalgia patients have findings suggestive of chronic inflammatory demyelinating polyneuropathy and appear to respond to IVIg.
Caro XJ; Winter EF; Dumas AJ
Rheumatology (Oxford); 2008 Feb; 47(2):208-11. PubMed ID: 18208823
[TBL] [Abstract][Full Text] [Related]
13. Development of weakness in patients with chronic inflammatory demyelinating polyneuropathy and only sensory symptoms at presentation: a long-term follow-up study.
van Dijk GW; Notermans NC; Franssen H; Wokke JH
J Neurol; 1999 Dec; 246(12):1134-9. PubMed ID: 10653304
[TBL] [Abstract][Full Text] [Related]
14. Symptoms of activity-induced weakness in peripheral nervous system disorders.
Straver DC; van den Berg LH; van Doorn PA; Franssen H
J Peripher Nerv Syst; 2011 Jun; 16(2):108-12. PubMed ID: 21692909
[TBL] [Abstract][Full Text] [Related]
15. Atypical childhood chronic inflammatory demyelinating polyneuropathy.
Mohamed AR; Rodriguez-Casero MV; Ryan MM
Muscle Nerve; 2010 Aug; 42(2):293-5. PubMed ID: 20589891
[TBL] [Abstract][Full Text] [Related]
16. Restless legs syndrome in chronic inflammatory demyelinating polyneuropathy.
Rajabally YA; Shah RS
Muscle Nerve; 2010 Aug; 42(2):252-6. PubMed ID: 20544936
[TBL] [Abstract][Full Text] [Related]
17. Clinical characteristics, and impairment and disability scale scores for different CIDP Disease Activity Status classes.
Alabdali M; Abraham A; Alsulaiman A; Breiner A; Barnett C; Katzberg HD; Lovblom LE; Perkins BA; Bril V
J Neurol Sci; 2017 Jan; 372():223-227. PubMed ID: 28017218
[TBL] [Abstract][Full Text] [Related]
18. Differences in peripheral myelin antigen-specific T cell responses and T memory subsets in atypical versus typical CIDP.
Staudt M; Diederich JM; Meisel C; Meisel A; Klehmet J
BMC Neurol; 2017 Apr; 17(1):81. PubMed ID: 28446142
[TBL] [Abstract][Full Text] [Related]
19. Different electrophysiological profiles and treatment response in 'typical' and 'atypical' chronic inflammatory demyelinating polyneuropathy.
Kuwabara S; Isose S; Mori M; Mitsuma S; Sawai S; Beppu M; Sekiguchi Y; Misawa S
J Neurol Neurosurg Psychiatry; 2015 Oct; 86(10):1054-9. PubMed ID: 25424435
[TBL] [Abstract][Full Text] [Related]
20. Axonal loss in patients with inflammatory demyelinating polyneuropathy as determined by motor unit number estimation and MUNIX.
Paramanathan S; Tankisi H; Andersen H; Fuglsang-Frederiksen A
Clin Neurophysiol; 2016 Jan; 127(1):898-904. PubMed ID: 26049677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
